In The News Posted November 25, 2020 Share Posted November 25, 2020 NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts